Target intelligence / Profile preview

β(1,3)-D-glucan synthase

Molecular classification
Enzyme, Glycosyltransferase, GT48
01

Overview

β(1,3)-D-glucan synthase is a membrane-bound enzyme complex responsible for synthesizing (1,3)-β-D-glucan, a major structural polysaccharide in the fungal cell wall. This enzyme is essential for fungal viability and serves as a key pharmacological target for antifungal drugs such as echinocandins (e.g., caspofungin, anidulafungin, micafungin) and ibrexafungerp. It catalyzes the polymerization of UDP-glucose to form linear (1,3)-β-D-glucan chains. The product forms the primary scaffold of the fungal cell wall and is critical for maintaining cell shape and integrity. Inhibition of β(1,3)-D-glucan synthase disrupts fungal cell wall synthesis leading to osmotic instability and ultimately cell death—making it an effective antifungal drug target. Resistance can arise via mutations in FKS genes encoding its catalytic subunits. Found widely among fungi including pathogenic species (Candida, Aspergillus, Cryptococcus, Pneumocystis) but absent from mammalian cells—contributing to its value as an antifungal target.

Other names
GS-IIParamylon synthetaseCallose synthase
02

Mechanism of action

Inhibition of β(1,3)-D-glucan synthase, disrupting fungal cell wall synthesis

03

Biological functions

Cell wall synthesisSeptum formationAscospore wall assembly
04

Disease associations

Infection
05

Safety considerations

Resistance can arise via mutations in FKS genes
06

Interacting drugs

Caspofungin

3 more in the full profile.

Beyond the preview

Go deeper on β(1,3)-D-glucan synthase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on β(1,3)-D-glucan synthase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call